281 related articles for article (PubMed ID: 23466816)
1. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
2. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
3. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
4. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
[TBL] [Abstract][Full Text] [Related]
6. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
[TBL] [Abstract][Full Text] [Related]
7. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
9. Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.
Llanos AA; Krok JL; Peng J; Pennell ML; Vitolins MZ; Degraffinreid CR; Paskett ED
Horm Cancer; 2014 Apr; 5(2):98-103. PubMed ID: 24435584
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.
White DL; Hoogeveen RC; Chen L; Richardson P; Ravishankar M; Shah P; Tinker L; Rohan T; Whitsel EA; El-Serag HB; Jiao L
Cancer Med; 2018 May; 7(5):2180-2191. PubMed ID: 29573228
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
12. Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial.
Llanos AA; Peng J; Pennell ML; Krok JL; Vitolins MZ; Degraffinreid CR; Paskett ED
J Clin Endocrinol Metab; 2014 Feb; 99(2):625-32. PubMed ID: 24423335
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
[TBL] [Abstract][Full Text] [Related]
14. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
[TBL] [Abstract][Full Text] [Related]
15. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
[TBL] [Abstract][Full Text] [Related]
16. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease.
Catsburg C; Gunter MJ; Chen C; Cote ML; Kabat GC; Nassir R; Tinker L; Wactawski-Wende J; Page DL; Rohan TE
Cancer Res; 2014 Jun; 74(12):3248-58. PubMed ID: 24755474
[TBL] [Abstract][Full Text] [Related]
17. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.
Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
Am J Epidemiol; 2013 Jan; 177(1):3-13. PubMed ID: 23171880
[TBL] [Abstract][Full Text] [Related]
18. The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
Ermakov S; Azarbal F; Stefanick ML; LaMonte MJ; Li W; Tharp KM; Martin LW; Nassir R; Salmoirago-Blotcher E; Albert CM; Manson JE; Assimes TL; Hlatky MA; Larson JC; Perez MV
Heart; 2016 Sep; 102(17):1354-62. PubMed ID: 27146694
[TBL] [Abstract][Full Text] [Related]
19. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
[TBL] [Abstract][Full Text] [Related]
20. Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women.
Gupta V; Mishra S; Mishra S; Kumar S; Gupta V
Immunol Lett; 2018 Apr; 196():63-67. PubMed ID: 29410303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
